ImmuCell (NASDAQ:ICCC – Get Free Report) will issue its quarterly earnings data after the market closes on Monday, November 13th. Investors that are interested in registering for the company’s conference call can do so using this link.
ImmuCell (NASDAQ:ICCC – Get Free Report) last released its quarterly earnings results on Thursday, August 10th. The biotechnology company reported ($0.18) EPS for the quarter. ImmuCell had a negative return on equity of 20.51% and a negative net margin of 38.36%. The company had revenue of $3.53 million for the quarter.
ImmuCell Trading Down 4.8 %
Shares of ImmuCell stock opened at $5.20 on Friday. The company has a quick ratio of 0.81, a current ratio of 2.61 and a debt-to-equity ratio of 0.32. The business has a fifty day simple moving average of $5.08 and a 200-day simple moving average of $5.12. ImmuCell has a fifty-two week low of $4.26 and a fifty-two week high of $8.48. The firm has a market cap of $40.30 million, a price-to-earnings ratio of -6.67 and a beta of 0.64.
Institutional Trading of ImmuCell
ImmuCell Company Profile
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E.
- Five stocks we like better than ImmuCell
- When to Sell a Stock for Profit or Loss
- Data giants MongoDB and Snowflake just got upgraded
- Bank Stocks – Best Bank Stocks to Invest In
- Plug Power at tipping point; it’s make or break time for hydrogen
- Industrial Products Stocks Investing
- Palantir’s Q3 earnings beat: Time to buy despite analyst caution?
Receive News & Ratings for ImmuCell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuCell and related companies with MarketBeat.com's FREE daily email newsletter.